Skip to main content
Clinical Trials/ChiCTR1800017821
ChiCTR1800017821Active, not recruiting基础科学研究

带状疱疹后遗神经痛患者皮肤的差异分子研究

自筹1 site in 1 country25 target enrollmentStarted: September 1, 2018Last updated:
Conditions

Trial Snapshot

Phase
基础科学研究
Status
Active, not recruiting
Sponsor
Enrollment
25
Locations
1
Primary Endpoint
microRNA

Study Overview

Brief Summary

观察带状疱疹后遗神经痛患者皮肤的分子改变

Study Design

Study Type
病因学/相关因素研究
Primary Purpose
单臂
Masking
非盲法试验

Eligibility Criteria

Ages
50 to 80 (—)
Sex
All

Inclusion Criteria

  • 1)依据《神经病理性疼痛诊疗学》诊断标准,两个以上高级职称疼痛科医师同时诊断为带状疱疹后遗神经痛; 2)心电图结果为正常心电图; 3)疱疹区域为胸段脊神经分布区域(T1-T12); 4)疱疹区域疼痛时间为 1-6 月; 5)NRS 疼痛评分为 6-10 分; 6)年龄为 50-80 岁。

Exclusion Criteria

  • 1)利多卡因过敏或其他药物过敏; 2)检查结果提示并存其他系统疾病; 3)疼痛剧烈,除常规治疗,需增加其他治疗措施患者。 4)焦虑抑郁评分提示明显焦虑抑郁状态(HAD 量表评分>11 分); 5)重要系统并发症,如 COPD、心脏病等; 6)除 PHN 疼痛外,合并其他疼痛及其他慢性疼痛疾病。

Arms & Interventions

Case series

Nil

Outcomes

Primary Outcomes

microRNA

circular RNA

炎症因子

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
自筹

Study Sites (1)

Loading locations...

Similar Trials

带状疱疹后遗神经痛患者皮肤的分子改变 | Clinical Trial